Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Transporter 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03951805
What this trial is testing

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 205
Not applicableNot Yet RecruitingNCT07678151
What this trial is testing

Finerenone and Empagliflozin Combination in Obesity With Hypertension: A 12-Week Prospective, Parallel-design, Double-blind, Randomized, Placebo-controlled Trial

Who this might be right for
Hypertension (HTN)
Heart Health Research Center 260
Post-approval studies (Phase 4)Looking for participantsNCT07323524
What this trial is testing

Dapagliflozin in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Brigham and Women's Hospital 33
Not applicableStudy completedNCT05313529
What this trial is testing

LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusMild Cognitive Impairment
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 396
Not applicableUnknownNCT05612269
What this trial is testing

SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study

Who this might be right for
CancerDiabetes Mellitus, Type 2Interleukin 6+1 more
Ministry of Health, Saudi Arabia 200
Early research (Phase 1)Study completedNCT02404870
What this trial is testing

Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers

Who this might be right for
Healthy Volunteers
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 67
Post-approval studies (Phase 4)Study completedNCT04461041
What this trial is testing

Empagliflozin and Cardiac Remodelling in People Without Diabetes

Who this might be right for
Cardiovascular DiseasesLeft Ventricular Hypertrophy
Unity Health Toronto 169
Large-scale testing (Phase 3)Looking for participantsNCT07025629
What this trial is testing

Dapagliflozin for Cardio-renal Protection After ICU Discharge

Who this might be right for
Heart Failure and Chronic Kidney Disease Post-ICU
Assistance Publique - Hôpitaux de Paris 600
Testing effectiveness (Phase 2)Looking for participantsNCT06843902
What this trial is testing

Improving Coronary Vascular Health in Women

Who this might be right for
HIV-1-infectionCoronary Microvascular DysfunctionMetabolic Disease
Massachusetts General Hospital 80
Post-approval studies (Phase 4)Study completedNCT07541456
What this trial is testing

Empagliflozin Versus Non-SGLT2 Oral Drugs for Blood Pressure in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusHypertension
Dr. Zarmina Younes 300
Not applicableStudy completedNCT06432751
What this trial is testing

Pre-operative Exposure to SGLT2 Inhibitors and Post-operative Acute Renal Failure in Cardiac Surgery

Who this might be right for
Acute Kidney InjuryCardiac SurgerySodium/Glucose Cotransporter Inhibitor 2
Hospices Civils de Lyon 500
Post-approval studies (Phase 4)Looking for participantsNCT06782139
What this trial is testing

Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity

Who this might be right for
Obesity and Type 2 Diabetes
Korea University Anam Hospital 30
Large-scale testing (Phase 3)Study completedNCT04035031
What this trial is testing

Effects of Dapagliflozin on Hormonal Glucose Homeostasis in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Insel Gruppe AG, University Hospital Bern 13
Post-approval studies (Phase 4)Study completedNCT05741658
What this trial is testing

The Fontan Dapagliflozin Pilot Study

Who this might be right for
Heart Failure
Johns Hopkins University 29
Not applicableUnknownNCT03557138
What this trial is testing

Study to Develop a Kinetic Model for FDG and Me4FDG in Kidneys of Type 2 Diabetic Patients

Who this might be right for
Type2 Diabetes Mellitus
Medical University of Vienna 20
Large-scale testing (Phase 3)Ended earlyNCT03933956
What this trial is testing

Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN)

Who this might be right for
Diabetic Nephropathies
Singapore General Hospital 2
Testing effectiveness (Phase 2)Looking for participantsNCT06929169
What this trial is testing

Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study

Who this might be right for
Chronic Kidney Disease Requiring Hemodialysis
Maximo Agustin Schiavone 80
Post-approval studies (Phase 4)Looking for participantsNCT07776054
What this trial is testing

Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF

Who this might be right for
Atrial FibrillationSGLT2 InhibitorDC Cardioversion
Samsung Medical Center 200
Post-approval studies (Phase 4)UnknownNCT06442280
What this trial is testing

SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF

Who this might be right for
Heart Failure AcuteDiabetes Type 2Heart Failure With Reduced Ejection Fraction+1 more
University of Palermo 544
Testing effectiveness (Phase 2)Looking for participantsNCT07245069
What this trial is testing

Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients

Who this might be right for
Heart FailureAnthracycline-induced Cardiac ToxicityEndothelial Function (FMD)+2 more
University Medical Centre Ljubljana 100
Next Page